Please use this identifier to cite or link to this item:
Title: Statins: Are Lipid-lowering Drugs Useful in Sarcomas?
Authors: Garcia Castellano, Jose Manuel 
Martínez Aragón, Nerea
García Padrón, David
Guerra Hernández, Carlos Borja 
Ramírez Sánchez, Margarita
Vera Gutiérrez, Vicente
Garcés Martín, Gerardo 
Fernández Pérez, Leandro Fco 
UNESCO Clasification: 32 Ciencias médicas
Keywords: Sarcoma
Cholesterol metabolism
Statin, et al
Issue Date: 2022
Publisher: INTECH OPEN
Abstract: Sarcomas are rare tumors that are difficult to treat. Many of them are chemo-resistant and with a high tendency to recur. Hence, finding new treatments is imperative in these tumors. Metabolic changes in tumor biology have become an essential characteristic in carcinogenesis processes, highlighting among them the role of lipids in these events, mainly cholesterol biosynthesis. Statins, inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoAR), a key enzyme in the mevalonate pathway responsible for cholesterol synthesis, have an effect beyond the reduction in plasma cholesterol levels. These are the so-called pleiotropic effects of statins, responsible for some of the antitumor action of statins. Although there are considerable epidemiological and preclinical evidences that support the use of these medicaments in the treatment of sarcomas as adjuvant reprofiled drugs, clinical trials are disparate and heterogeneous, and do not provide enough information to help determine the convenience of their use, being necessary more studies to evaluate the efficacy and safety of statins in sarcomas. The purpose of this review is to update the role played by the reprofiled statins in the treatment of sarcomas.
DOI: 10.5772/intechopen.107127
Source: Bone Tumors - Recent Updates
Appears in Collections:Capítulo de libro
Adobe PDF (1,99 MB)
Show full item record

Page view(s)

checked on Mar 18, 2023


checked on Mar 18, 2023

Google ScholarTM




Export metadata

Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.